Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Katsenos, A. Antonopoulou, E. Apostolidou, A. Ioakeimidou, G. Kalpakou, M. Papanikolaou, A. Pistiki, Margarita Mpalla, M. Paraschos, M. Patrani, M. Pratikaki, Theodoros Retsas, A. Savva, Spyridoula Vassiliagkou, A. Lekkou, I. Dimopoulou, C. Routsi, K. Mandragos (2014)
Early Administration of Hydrocortisone Replacement After the Advent of Septic Shock: Impact on Survival and Immune Response*Critical Care Medicine, 42
(2016)
Surviving sepsis campaign : international guidelines for management of sepsis and septic shock :
B. Venkatesh, S. Finfer, Jeremy Cohen, D. Rajbhandari, Y. Arabi, R. Bellomo, L. Billot, Maryam Correa, P. Glass, M. Harward, C. Joyce, Qiang Li, C. McArthur, A. Perner, A. Rhodes, Kelly Thompson, S. Webb, J. Myburgh (2018)
Adjunctive Glucocorticoid Therapy in Patients with Septic ShockThe New England Journal of Medicine, 378
Xue-zhong Xing, Hai-jun Wang, Chu-lin Huang, Quan-Hui Yang, S. Qu, Hao Zhang, Hao Wang, Yong Gao, Qing-ling Xiao, K. Sun (2013)
Prognosis of patients with shock receiving vasopressors.World journal of emergency medicine, 4 1
Ashish Khanna, M. Ostermann, R. Bellomo (2017)
Angiotensin II for the Treatment of Vasodilatory Shock.The New England journal of medicine, 377 26
A. Rhodes, Laura Evans, W. Alhazzani, M. Levy, M. Antonelli, R. Ferrer, Anand Kumar, J. Sevransky, C. Sprung, M. Nunnally, B. Rochwerg, G. Rubenfeld, D. Angus, D. Annane, R. Beale, G. Bellinghan, G. Bernard, J. Chiche, C. Coopersmith, D. Backer, C. French, S. Fujishima, H. Gerlach, J. Hidalgo, S. Hollenberg, A. Jones, D. Karnad, R. Kleinpell, Y. Koh, T. Lisboa, F. Machado, J. Marini, J. Marshall, J. Mazuski, L. McIntyre, A. McLean, S. Mehta, R. Moreno, J. Myburgh, P. Navalesi, O. Nishida, T. Osborn, A. Perner, Colleen Plunkett, M. Ranieri, C. Schorr, Maureen Seckel, C. Seymour, L. Shieh, K. Shukri, S. Simpson, M. Singer, B. Thompson, S. Townsend, T. Poll, J. Vincent, W. Wiersinga, J. Zimmerman, R. Dellinger (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2016Critical Care Medicine, 45
Q. Lv, X. Gu, Qi-hong Chen, Jiang-quan Yu, R. Zheng (2017)
Early initiation of low‐dose hydrocortisone treatment for septic shock in adults: A randomized clinical trialAmerican Journal of Emergency Medicine, 35
Anand Kumar, D. Roberts, K. Wood, B. Light, J. Parrillo, S. Sharma, R. Suppes, D. Feinstein, S. Zanotti, Leo Taiberg, David Gurka, Aseem Kumar, M. Cheang (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 34
H. Park, G. Suh, J. Song, H. Yoo, I. Jo, T. Shin, S. Lim, S. Woo, K. Jeon (2012)
Early initiation of low-dose corticosteroid therapy in the management of septic shock: a retrospective observational studyCritical Care, 16
C. Sprung, D. Annane, D. Keh, R. Moreno, M. Singer, K. Freivogel, Y. Weiss, J. Benbenishty, A. Kalenka, H. Forst, P. Laterre, K. Reinhart, B. Cuthbertson, D. Payen, J. Briegel (2008)
Hydrocortisone therapy for patients with septic shock.The New England journal of medicine, 358 2
J. Russell, K. Walley, J. Singer, A. Gordon, Paul Hébert, D. Cooper, C. Holmes, S. Mehta, J. Granton, Michelle Storms, D. Cook, J. Presneill, D. Ayers (2008)
Vasopressin versus norepinephrine infusion in patients with septic shock.The New England journal of medicine, 358 9
N. Steigbigel (2003)
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shockCurrent Infectious Disease Reports, 5
C. Paoli, M. Reynolds, Meenal Sinha, M. Gitlin, E. Crouser (2018)
Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level*Critical Care Medicine, 46
D. Annane, A. Renault, C. Brun-Buisson, B. Mégarbane, J. Quenot, S. Siami, A. Cariou, X. Forceville, C. Schwebel, Claude Martin, J. Timsit, B. Misset, M. Benali, G. Colin, B. Souweine, K. Asehnoune, E. Mercier, L. Chimot, C. Charpentier, B. François, T. Boulain, F. Petitpas, J. Constantin, G. Dhonneur, F. Baudin, A. Combes, J. Bohé, J. Loriferne, R. Amathieu, F. Cook, M. Slama, O. Leroy, G. Capellier, A. Dargent, T. Hissem, V. Maxime, É. Bellissant (2018)
Hydrocortisone plus Fludrocortisone for Adults with Septic ShockThe New England Journal of Medicine, 378
Dora Liu, A. Ahmet, L. Ward, Preetha Krishnamoorthy, E. Mandelcorn, R. Leigh, Jacques Brown, A. Cohen, Harold Kim (2013)
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapyAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 9
M. McCarron, J. Frank (1964)
Septic ShockAnnals of Pharmacotherapy, 7
M. Shankar-Hari, Gary Phillips, M. Levy, C. Seymour, Vincent Liu, C. Deutschman, D. Angus, G. Rubenfeld, M. Singer (2016)
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).JAMA, 315 8
S. Zhang, W. Chang, Jianfeng Xie, Zongsheng Wu, Yi Yang, H. Qiu (2020)
The Efficacy, Safety, and Optimal Regimen of Corticosteroids in Sepsis: A Bayesian Network Meta-AnalysisCritical Care Explorations, 2
Background:Multiple publications demonstrate an association between time to initiation of corticosteroids and outcomes such as mortality and reversal of shock. However, the optimal time to initiate hydrocortisone remains unknown.Objective:To evaluate the impact of early versus late initiation of hydrocortisone in septic shock patients.Methods:A retrospective, multicentered, observational study was conducted. Adults admitted from July 1, 2014, to August 31, 2019, diagnosed with septic shock receiving vasopressors and low-dose hydrocortisone were evaluated. Participants were divided into the “early” group if hydrocortisone was initiated within 12 hours or “late” group if initiated after 12 hours of vasopressor initiation. The primary outcome was time to vasopressor discontinuation. Secondary outcomes included in-hospital mortality, intensive care unit (ICU) and hospital length of stay (LOS), vasopressor utilization, fluids administered, and need for renal replacement therapy.Results:A total of 198 patients were identified for inclusion in this propensity score–weighted cohort: 99 in the early group and 99 in the late group. Early initiation was associated with shorter time to vasopressor discontinuation compared with late initiation (40.7 vs 60.6 hours; P = 0.0002). There was also a reduction in ICU LOS (3.6 vs 5.1 days; P = 0.0147) and hospital LOS (8.9 vs 10.9 days; P = 0.0220) seen in the early group. There was no difference in mortality between groups.Conclusion and Relevance:In this propensity-matched cohort, administration of hydrocortisone within 12 hours from the onset of septic shock was associated with improved time to vasopressor discontinuation and reduced ICU and hospital LOS.
Annals of Pharmacotherapy – SAGE
Published: Mar 1, 2022
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.